Related Experiment Video
Updated: May 4, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
12.9K
Pharmacological treatments for smoking cessation
Kate Cahill1, Sarah Stevens2, Tim Lancaster1
1Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom2Cochrane Tobacco Addiction Group, University of Oxford, Oxford, United Kingdom.
JAMA
|January 9, 2014
Summary
Nicotine replacement therapy (NRT) and bupropion show higher smoking cessation rates than placebo. Varenicline and combination NRT are most effective, with no serious adverse events linked to any treatment.
Area of Science:
- Pharmacology
- Addiction Medicine
- Public Health
Background:
- Smoking remains a leading cause of preventable death worldwide.
- Effective first-line pharmacotherapies are crucial for smoking cessation.
- Nicotine replacement therapy (NRT), bupropion, and varenicline are established treatments.
Purpose of the Study:
- To compare the efficacy of NRT, bupropion, and varenicline for long-term smoking abstinence.
- To assess serious adverse events associated with these first-line smoking cessation aids.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials.
- Inclusion of studies evaluating nicotine replacement therapy (NRT), bupropion, and varenicline.
- Assessment of smoking cessation rates at 6 months or longer and serious adverse event incidence.
Main Results:
- NRT (17.6%) and bupropion (19.1%) demonstrated higher cessation rates compared to placebo (10.6%).
- Varenicline (27.6%) and combination NRT (31.5%) showed the highest efficacy in achieving smoking cessation.
- No significant increase in serious adverse events was observed for any of the active treatments versus placebo.
Conclusions:
- Varenicline and combination NRT are the most effective first-line pharmacotherapies for smoking cessation.
- All evaluated treatments, including NRT, bupropion, and varenicline, are safe regarding serious adverse events.
- These findings support the use of varenicline and combination NRT for individuals seeking to quit smoking.
More Related Videos
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:27CNS Depressants: Alcohol and Nicotine
1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:17Drug Dependence
1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K